David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.36% |
| 2 | Technology | 13.15% |
| 3 | Financials | 9.51% |
| 4 | Healthcare | 7.52% |
| 5 | Consumer Discretionary | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Samsara
IOT
$24.5B
| $1.28M | ﹤0.01% |
105,747
+70,370
| +199% | +$997K |
|
3252
Puma Biotechnology
PBYI
$477M
| $1.28M | ﹤0.01% |
538,544
-421,528
| -44% | -$1.23M |
|
3253
OneSpan
OSPN
$613M
| $1.27M | ﹤0.01% |
147,998
+60,559
| +69% | +$654K |
|
3254
Ovid Therapeutics
OVID
$564M
| $1.27M | ﹤0.01% |
691,323
-198,041
| -22% | -$414K |
|
3255
PUT
Southern Company
SO
$102B
| $1.27M | ﹤0.01% |
18,700
+3,300
| +21% | +$250K |
|
3256
CALL
Lumentum
LITE
$85.5B
| $1.27M | ﹤0.01% |
18,500
| – | – |
|
3257
Inspired Entertainment
INSE
$156M
| $1.27M | ﹤0.01% |
143,613
+88,535
| +161% | +$913K |
|
3258
Orthofix Medical
OFIX
$396M
| $1.27M | ﹤0.01% |
66,315
+14,713
| +29% | +$331K |
|
|
DFS
3259
CALL
DELISTED
Discover Financial Services
DFS
| $1.26M | ﹤0.01% |
13,900
| – | – |
|
3260
PUT
Chegg
CHGG
$91.3M
| $1.26M | ﹤0.01% |
59,900
-63,700
| -52% | -$1.32M |
|
3261
PUT
Matador Resources
MTDR
$7.01B
| $1.26M | ﹤0.01% |
25,800
+800
| +3% | +$43.2K |
|
3262
Fidelity National Financial
FNF
$12.7B
| $1.26M | ﹤0.01% |
36,226
-268,951
| -88% | -$10M |
|
3263
Photronics
PLAB
$1.76B
| $1.26M | ﹤0.01% |
86,297
+14,489
| +20% | +$285K |
|
3264
Genesco
GCO
$368M
| $1.26M | ﹤0.01% |
32,056
+23,435
| +272% | +$1.25M |
|
3265
Matrix Service
MTRX
$308M
| $1.26M | ﹤0.01% |
304,271
-4,401
| -1% | -$22.6K |
|
3266
Ezcorp Inc
EZPW
$2.12B
| $1.25M | ﹤0.01% |
162,656
+29,851
| +22% | +$247K |
|
3267
OptimizeRx
OPRX
$148M
| $1.25M | ﹤0.01% |
+84,429
| New | +$1.67M |
|
3268
Polestar Automotive Holding UK
PSNY
$1.79B
| $1.25M | ﹤0.01% |
+8,243
| New | +$2.07M |
|
|
HWKZ
3269
DELISTED
Hawks Acquisition Corp
HWKZ
| $1.25M | ﹤0.01% |
127,154
| – | – |
|
|
INBX
3270
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.25M | ﹤0.01% |
69,719
-51,293
| -42% | -$925K |
|
|
LYLT
3271
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
| $1.25M | ﹤0.01% |
1,031,791
+426,419
| +70% | +$1.11M |
|
|
PLMJ
3272
DELISTED
Plum Acquisition Corp. III Class A Ordinary Shares
PLMJ
| $1.25M | ﹤0.01% |
126,736
+115
| +0.1% | +$1.12K |
|
3273
Archer Daniels Midland
ADM
$38.2B
| $1.24M | ﹤0.01% |
15,464
-140,575
| -90% | -$11.6M |
|
3274
Seacoast Banking Corp of Florida
SBCF
$3.31B
| $1.24M | ﹤0.01% |
41,108
+32,367
| +370% | +$1.08M |
|
|
VXRT
3275
DELISTED
Vaxart
VXRT
| $1.24M | ﹤0.01% |
569,957
-470,429
| -45% | -$1.62M |
|
Similar funds
David Shaw's Q3 2022 Portfolio in Review
As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
David Shaw withdrew a net $7.97B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in Prologis worth $66.1M.
- David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
- David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- David Shaw opened 545 new positions and closed 678 in Q3 2022.
- David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.